199 related articles for article (PubMed ID: 29421780)
1. Luteolin Modulates SERCA2a Leading to Attenuation of Myocardial Ischemia/ Reperfusion Injury via Sumoylation at Lysine 585 in Mice.
Du Y; Liu P; Xu T; Pan D; Zhu H; Zhai N; Zhang Y; Li D
Cell Physiol Biochem; 2018; 45(3):883-898. PubMed ID: 29421780
[TBL] [Abstract][Full Text] [Related]
2. Luteolin Enhances Sarcoplasmic Reticulum Ca2+-ATPase Activity through p38 MAPK Signaling thus Improving Rat Cardiac Function after Ischemia/Reperfusion.
Zhu S; Xu T; Luo Y; Zhang Y; Xuan H; Ma Y; Pan D; Li D; Zhu H
Cell Physiol Biochem; 2017; 41(3):999-1010. PubMed ID: 28222421
[TBL] [Abstract][Full Text] [Related]
3. Luteolin improves cardiac dysfunction in heart failure rats by regulating sarcoplasmic reticulum Ca
Hu W; Xu T; Wu P; Pan D; Chen J; Chen J; Zhang B; Zhu H; Li D
Sci Rep; 2017 Jan; 7():41017. PubMed ID: 28112209
[TBL] [Abstract][Full Text] [Related]
4. Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice.
Hu Y; Zhang C; Zhu H; Wang S; Zhou Y; Zhao J; Xia Y; Li D
Sci Rep; 2020 Sep; 10(1):15407. PubMed ID: 32958799
[TBL] [Abstract][Full Text] [Related]
5. Zinc-Induced SUMOylation of Dynamin-Related Protein 1 Protects the Heart against Ischemia-Reperfusion Injury.
Bian X; Xu J; Zhao H; Zheng Q; Xiao X; Ma X; Li Y; Du X; Liu X
Oxid Med Cell Longev; 2019; 2019():1232146. PubMed ID: 31428220
[TBL] [Abstract][Full Text] [Related]
6. Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.
Bian C; Xu T; Zhu H; Pan D; Liu Y; Luo Y; Wu P; Li D
PLoS One; 2015; 10(12):e0144877. PubMed ID: 26658785
[TBL] [Abstract][Full Text] [Related]
7. SUMO1-dependent modulation of SERCA2a in heart failure.
Kho C; Lee A; Jeong D; Oh JG; Chaanine AH; Kizana E; Park WJ; Hajjar RJ
Nature; 2011 Sep; 477(7366):601-5. PubMed ID: 21900893
[TBL] [Abstract][Full Text] [Related]
8. ERK/PP1a/PLB/SERCA2a and JNK pathways are involved in luteolin-mediated protection of rat hearts and cardiomyocytes following ischemia/reperfusion.
Wu X; Xu T; Li D; Zhu S; Chen Q; Hu W; Pan D; Zhu H; Sun H
PLoS One; 2013; 8(12):e82957. PubMed ID: 24386130
[TBL] [Abstract][Full Text] [Related]
9. Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure.
Liu Z; Bian X; Gao W; Su J; Ma C; Xiao X; Yu T; Zhang H; Liu X; Fan G
Pharmacol Res; 2021 Oct; 172():105843. PubMed ID: 34428586
[TBL] [Abstract][Full Text] [Related]
10. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion.
Fang F; Li D; Pan H; Chen D; Qi L; Zhang R; Sun H
Pharmacology; 2011; 88(3-4):149-58. PubMed ID: 21934351
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
12. SHP-1/STAT3 Interaction Is Related to Luteolin-Induced Myocardial Ischemia Protection.
Liu D; Luo H; Qiao C
Inflammation; 2022 Feb; 45(1):88-99. PubMed ID: 34460026
[TBL] [Abstract][Full Text] [Related]
13. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway.
Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT
J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682
[TBL] [Abstract][Full Text] [Related]
14. Antioxidative effect of luteolin pretreatment on simulated ischemia/reperfusion injury in cardiomyocyte and perfused rat heart.
Zhang RQ; Li DY; Xu TD; Zhu SS; Pan HJ; Fang F; Wu X; Sun H
Chin J Integr Med; 2017 Jul; 23(7):518-527. PubMed ID: 26956461
[TBL] [Abstract][Full Text] [Related]
15. Melatonin-Induced Protective Effects on Cardiomyocytes Against Reperfusion Injury Partly Through Modulation of IP3R and SERCA2a Via Activation of ERK1.
Hu S; Zhu P; Zhou H; Zhang Y; Chen Y
Arq Bras Cardiol; 2018 Jan; 110(1):44-51. PubMed ID: 29538523
[TBL] [Abstract][Full Text] [Related]
16. SENP2-mediated SERCA2a deSUMOylation increases calcium overload in cardiomyocytes to aggravate myocardial ischemia/reperfusion injury.
Luo Y; Zhou S; Xu T; Wu W; Shang P; Wang S; Pan D; Li D
Chin Med J (Engl); 2023 Oct; 136(20):2496-2507. PubMed ID: 37462038
[TBL] [Abstract][Full Text] [Related]
17. HAX-1 regulates SERCA2a oxidation and degradation.
Bidwell PA; Liu GS; Nagarajan N; Lam CK; Haghighi K; Gardner G; Cai WF; Zhao W; Mugge L; Vafiadaki E; Sanoudou D; Rubinstein J; Lebeche D; Hajjar R; Sadoshima J; Kranias EG
J Mol Cell Cardiol; 2018 Jan; 114():220-233. PubMed ID: 29169992
[TBL] [Abstract][Full Text] [Related]
18. Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis.
Xu T; Zhang Y; Liao G; Xuan H; Yin J; Bao J; Liu Y; Li D
Anal Cell Pathol (Amst); 2023; 2023():4500810. PubMed ID: 38077523
[TBL] [Abstract][Full Text] [Related]
19. Luteolin Exerts Cardioprotective Effects through Improving Sarcoplasmic Reticulum Ca(2+)-ATPase Activity in Rats during Ischemia/Reperfusion In Vivo.
Nai C; Xuan H; Zhang Y; Shen M; Xu T; Pan D; Zhang C; Zhang Y; Li D
Evid Based Complement Alternat Med; 2015; 2015():365854. PubMed ID: 26681967
[TBL] [Abstract][Full Text] [Related]
20. Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice.
Talukder MA; Kalyanasundaram A; Zuo L; Velayutham M; Nishijima Y; Periasamy M; Zweier JL
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1426-34. PubMed ID: 18203847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
